Tag: PolyPid
Phase 3 trial for D-PLEX100 technology to assess efficacy in preventing...
Pharmaceutical company PolyPid has announced that the first patient has been enrolled and randomised in a phase 3 clinical trial called SHIELD (Surgical site...